Keybanc analyst Matthew Mishan downgrades Cooper Companies (NYSE:COO) from Overweight to Sector Weight.
Anticipation Builds For Rain Oncology’s Phase 3 MANTRA Trial Results, Analyst Sees Promise
In early March, in its Q4 earnings release, Rain Oncology Inc (NASDAQ:RAIN) announced that the topline data from its Phase 3…